STAGE IIA BREAST CANCER
Clinical trials for STAGE IIA BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE IIA BREAST CANCER trials appear
Sign up with your email to follow new studies for STAGE IIA BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for aggressive breast cancer: which chemo works best after surgery?
Disease control OngoingThis study tests whether platinum-based chemotherapy (cisplatin or carboplatin) works better than capecitabine in people with a certain type of triple-negative breast cancer that still remains after initial chemotherapy and surgery. About 415 participants with stage II or III bre…
Matched conditions: STAGE IIA BREAST CANCER
Phase: PHASE3 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated May 26, 2026 11:39 UTC
-
New combo shrinks breast tumors before surgery, study shows
Disease control OngoingThis study tested whether adding trastuzumab to standard chemotherapy before surgery helps shrink breast tumors more effectively. About 92 women with early-stage breast cancer (some HER2-positive, some HER2-negative) took part. The goal was to see if the combination reduces the a…
Matched conditions: STAGE IIA BREAST CANCER
Phase: PHASE2 • Sponsor: University of Nebraska • Aim: Disease control
Last updated May 26, 2026 11:35 UTC
-
Shorter radiation after mastectomy may reduce side effects and prevent cancer return
Disease control OngoingThis study tests whether a shorter course of radiation (hypofractionated) after mastectomy works as well as standard radiation to prevent breast cancer from coming back. About 900 people with stage II to IIIA breast cancer took part. The shorter schedule aims to cause fewer side …
Matched conditions: STAGE IIA BREAST CANCER
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated May 26, 2026 11:34 UTC
-
New chemo combo shows promise for tough breast cancer
Disease control OngoingThis study tested a chemotherapy combination (carboplatin and nab-paclitaxel) given before surgery to people with a fast-growing type of breast cancer called triple negative. The goal was to shrink tumors enough so that no cancer remains at the time of surgery. The study included…
Matched conditions: STAGE IIA BREAST CANCER
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 26, 2026 11:30 UTC
-
One-Time radiation boost during breast surgery shows promise
Disease control OngoingThis study tests whether giving a single, strong dose of radiation directly to the tumor site during breast-conserving surgery (with reconstruction) is safe and effective for women with early-stage breast cancer. About 108 participants will receive this targeted radiation boost r…
Matched conditions: STAGE IIA BREAST CANCER
Phase: PHASE2 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
Single radiation dose during surgery may control early breast cancer
Disease control OngoingThis study tests giving a single dose of radiation directly to the area where a breast tumor was removed, right during surgery. It involves about 1,259 people with early-stage breast cancer. The goal is to see if this one-time treatment works as well as standard radiation and has…
Matched conditions: STAGE IIA BREAST CANCER
Phase: NA • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated May 22, 2026 13:52 UTC